-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Age-Related Molecular Changes in Burkitt Lymphoma

Program: Scientific Program
Session: JOINT SESSION: Molecular Characterization of Lymphomas in Children, Adolescents, and Young Adults
Hematology Disease Topics & Pathways:
Research, Translational Research
Saturday, December 7, 2024, 4:00 PM-5:35 PM

Birgit Burkhardt, MD, PhD

Pediatric Hematology, Oncology and BMT, University Hospital Münster, Muenster, Germany

Disclosures: Burkhardt: Miltenyi, Roche, Novartis, Janssen, AbbVie: Consultancy; Novartis: Membership on an entity's Board of Directors or advisory committees; Miltenyi: Consultancy; Roche: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding.

See more of: JOINT SESSION: Molecular Characterization of Lymphomas in Children, Adolescents, and Young Adults
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>